189 related articles for article (PubMed ID: 26250335)
41. miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression.
Hemmesi K; Squadrito ML; Mestdagh P; Conti V; Cominelli M; Piras IS; Sergi LS; Piccinin S; Maestro R; Poliani PL; Speleman F; De Palma M; Galli R
Stem Cells; 2015 May; 33(5):1377-89. PubMed ID: 25639612
[TBL] [Abstract][Full Text] [Related]
42. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
43. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
[TBL] [Abstract][Full Text] [Related]
44. Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line.
de la Rosa J; Sáenz Antoñanzas A; Shahi MH; Meléndez B; Rey JA; Castresana JS
Tumour Biol; 2016 Sep; 37(9):12359-12370. PubMed ID: 27306215
[TBL] [Abstract][Full Text] [Related]
45. [MicroRNA383 regulates expression of PRDX3 in human medulloblastomas].
Wang XM; Zhang SF; Cheng ZQ; Peng QZ; Hu JT; Gao LK; Xu J; Jin HT; Liu HY
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):547-52. PubMed ID: 23157748
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
[TBL] [Abstract][Full Text] [Related]
47. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
48. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
Guo R; Wu Q; Liu F; Wang Y
Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.
Venkataraman S; Alimova I; Fan R; Harris P; Foreman N; Vibhakar R
PLoS One; 2010 Jun; 5(6):e10748. PubMed ID: 20574517
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
[TBL] [Abstract][Full Text] [Related]
51. miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.
Kaid C; Jordan D; Bueno HMS; Araujo BHS; Assoni A; Okamoto OK
Mol Oncol; 2019 Dec; 13(12):2574-2587. PubMed ID: 31402560
[TBL] [Abstract][Full Text] [Related]
52. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
Iida H; Suzuki M; Goitsuka R; Ueno H
Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
[TBL] [Abstract][Full Text] [Related]
53. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
54. miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma.
Shi J; Yang L; Wang T; Zhang J; Guo X; Huo X; Niu H
Mol Med Rep; 2013 Oct; 8(4):1111-7. PubMed ID: 23970061
[TBL] [Abstract][Full Text] [Related]
55. Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition.
Singh SV; Dakhole AN; Deogharkar A; Kazi S; Kshirsagar R; Goel A; Moiyadi A; Jalali R; Sridhar E; Gupta T; Shetty P; Gadewal N; Shirsat NV
Biochem Biophys Res Commun; 2017 Sep; 491(4):946-952. PubMed ID: 28757413
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.
Fiaschetti G; Abela L; Nonoguchi N; Dubuc AM; Remke M; Boro A; Grunder E; Siler U; Ohgaki H; Taylor MD; Baumgartner M; Shalaby T; Grotzer MA
Br J Cancer; 2014 Feb; 110(3):636-47. PubMed ID: 24346283
[TBL] [Abstract][Full Text] [Related]
57. Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy.
Čančer M; Hutter S; Holmberg KO; Rosén G; Sundström A; Tailor J; Bergström T; Garancher A; Essand M; Wechsler-Reya RJ; Falk A; Weishaupt H; Swartling FJ
Cell Stem Cell; 2019 Dec; 25(6):855-870.e11. PubMed ID: 31786016
[TBL] [Abstract][Full Text] [Related]
58. Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment.
D'Asti E; Huang A; Kool M; Meehan B; Chan JA; Jabado N; Korshunov A; Pfister SM; Rak J
Am J Pathol; 2016 Feb; 186(2):446-59. PubMed ID: 26687818
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
[TBL] [Abstract][Full Text] [Related]
60. Astrocytes influence medulloblastoma phenotypes and CD133 surface expression.
Gronseth E; Gupta A; Koceja C; Kumar S; Kutty RG; Rarick K; Wang L; Ramchandran R
PLoS One; 2020; 15(7):e0235852. PubMed ID: 32628717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
